Evidence map›Paper›PMID 39381371›Full record

ArticleFrontiers in cell and developmental biology2024

Rapid genome-wide profiling of DNA methylation and genetic variation using guide positioning sequencing (GPS).

Baolong Zhang, Wei Li, Jin Li, Yan Li, Huaibing Luo, Yanping Xi, Shihua Dong, Feizhen Wu, Wenqiang Yu

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Baolong ZhangInstitutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
Wei LiInstitutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
Jin LiInstitutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
Yan LiInstitutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
Huaibing LuoInstitutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
Yanping XiInstitutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
Shihua DongInstitutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
Feizhen WuKey Laboratory of Medical Epigenetics and Metabolism, Institute of Clinical Science of Zhongshan Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Wenqiang YuInstitutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whole-genome bisulfite sequencing (WGBS) has been extensively utilized for DNA methylation profiling over the past decade. However, it has shown limitations in terms of high costs and inefficiencies. The productivity and accuracy of DNA methylation detection rely critically on the optimization of methodologies and the continuous refinements of related sequencing platforms. Here, we describe a detailed protocol of guide positioning sequencing (GPS), a bisulfite-based, location-specific sequencing technology designed for comprehensive DNA methylation characterization across the genome. The fundamental principle of GPS lies in the substitution of dCTP with 5-methyl-dCTP (5 mC) at the 3'-end of DNA fragments by T4 DNA polymerase, which protects cytosines from bisulfite conversion to preserve the integrity of the base composition. This alteration allows the 3'-end to independently facilitate genetic variation profiling and guides the 5'-end, enriched with methylation information, to align more rapidly to the reference genome. Hence, GPS enables the concurrent detection of both genetic and epigenetic variations. Additionally, we provide an accessible description of the data processing, specifically involving certain software and scripts. Overall, the entire GPS procedure can be completed within a maximum of 15 days, starting with a low initial DNA input of 100-500 ng, followed by 4-5 days for library construction, 8-10 days for high-throughput sequencing (HTS) and data analysis, which can greatly facilitate the promotion and application of DNA methylation detection, especially for the rapid clinical diagnosis of diverse disease pathologies associated with concurrent genetic and epigenetic variations.

Indexed as

DNA methylationgenetic and epigenetic variationsGPSprotocolT4 DNA polymerase

Identifiers

PMID39381371
PMCPMC11459621

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.